US Bancorp’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-504
| Closed | -$69K | – | 3779 |
|
|
2018
Q2 | $69K | Sell |
504
-855
| -63% | -$77.7K | ﹤0.01% | 2416 |
|
|
2018
Q1 | $107K | Buy |
1,359
+959
| +240% | +$70.8K | ﹤0.01% | 2201 |
|
|
2017
Q4 | $27K | Hold |
400
| – | – | ﹤0.01% | 2840 |
|
|
2017
Q3 | $16K | Hold |
400
| – | – | ﹤0.01% | 2984 |
|
|
2017
Q2 | $16K | Hold |
400
| – | – | ﹤0.01% | 2957 |
|
|
2017
Q1 | $13K | Buy |
+400
| New | +$9.98K | ﹤0.01% | 2985 |
|
|
2016
Q3 | – | Sell |
-11
| Closed | – | – | 3694 |
|
|
2016
Q2 | $0 | Hold |
11
| – | – | ﹤0.01% | 3715 |
|
|
2016
Q1 | $0 | Buy |
+11
| New | +$177 | ﹤0.01% | 3741 |
|
|
2015
Q3 | – | Sell |
-31
| Closed | -$1K | – | 3736 |
|
|
2015
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 3529 |
|
|
2015
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 3522 |
|
|
2014
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 3492 |
|
|
2014
Q3 | $1K | Hold |
31
| – | – | ﹤0.01% | 3469 |
|
|
2014
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 3455 |
|
|
2014
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 3439 |
|
|
2013
Q4 | $1K | Buy |
+31
| New | +$867 | ﹤0.01% | 3373 |
|
US Bancorp's FMI Position: Q3 2018 in Review
US Bancorp sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 504 shares — an estimated $69K sold.
US Bancorp first reported a position in FMI in Q4 2013 and held it in 15 quarters. The position peaked at $107K in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- US Bancorp reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- US Bancorp sold 504 Foundation Medicine, Inc. shares in Q3 2018, an estimated $69K.
- US Bancorp first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 15 quarters.
- US Bancorp's Foundation Medicine, Inc. position peaked at $107K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on US Bancorp's 13F filing for Q3 2018, filed 1 Nov 2018.